STMN1 promotes cell malignancy and bortezomib resistance of multiple myeloma cell lines via PI3K/AKT signaling

CONCLUSION: STMN1 silencing inhibits cell proliferation and BTZ resistance in MM by inactivating the PI3K/Akt signaling.PMID:37642368 | DOI:10.1080/14740338.2023.2251384

Source: Expert Opinion on Drug Safety - August 29, 2023 Category: Drugs & Pharmacology Authors: Ling Wang Jie Cao Yan Liang Jian Tao Source Type: research